Condition: Asthma
Interventions: Drug: Budesonide Inhalation Aerosol (PT008) Dose 1; Drug: Budesonide Inhalation Aerosol (PT008) Dose 2; Drug: Budesonide Inhalation Aerosol (PT008) Dose 3; Drug: Budesonide Inhalation Aerosol (PT008) Dose 4; Drug: Placebo
Sponsor: Pearl Therapeutics, Inc.
Not yet recruiting – verified April 2014
View full post on ClinicalTrials.gov: asthma | received in the last 14 days